GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ginwa Enterprise Group Inc (SHSE:600080) » Definitions » Buyback Yield %

Ginwa Enterprise Group (SHSE:600080) Buyback Yield % : 0.00 (As of May. 06, 2025)


View and export this data going back to 1997. Start your Free Trial

What is Ginwa Enterprise Group Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Ginwa Enterprise Group's current buyback yield was 0.00%.


Ginwa Enterprise Group Buyback Yield % Historical Data

The historical data trend for Ginwa Enterprise Group's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ginwa Enterprise Group Buyback Yield % Chart

Ginwa Enterprise Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ginwa Enterprise Group Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ginwa Enterprise Group's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Ginwa Enterprise Group's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ginwa Enterprise Group's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ginwa Enterprise Group's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Ginwa Enterprise Group's Buyback Yield % falls into.


;
;

Ginwa Enterprise Group Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Ginwa Enterprise Group's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 2915.2387
=0.00%

Ginwa Enterprise Group's annualized Buyback Yield for the quarter that ended in Mar. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 2818.1885
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .


Ginwa Enterprise Group Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Ginwa Enterprise Group's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ginwa Enterprise Group Business Description

Traded in Other Exchanges
N/A
Address
Gaoxin 3rd Road, 40th Floor, South Tower, Phase III, Fortune Center, Gaoxin District, Xi'an, CHN, 710075
Ginwa Enterprise Group Inc operates in the pharmaceutical industry. The main business is the research and development, production, and sales of drugs, and the product line covers chemical drugs, Chinese patent medicines, raw materials, and health products. The dosage forms include tablets, capsules, granules, powders, mixtures, oral solutions, syrups, external solutions, and more than 100 varieties and specifications.
Executives
Zhang Chao Yang Director
Zhang Mei Director
Tao Yu senior management
Qin Chuan Director
Hou Yi Wen senior management
Ge Xiu Li Supervisors

Ginwa Enterprise Group Headlines

No Headlines